Template talk:Main Page News: Difference between revisions
From Embryology
mNo edit summary |
mNo edit summary |
||
Line 1: | Line 1: | ||
The following are earlier versions of the news panel that appears on the website [[Main Page]]. | The following are earlier versions of the news panel that appears on the website [[Main Page]]. | ||
==2014== | ==2014== | ||
===March=== | |||
[[File:Chromosome- trisomy.jpg|250px|left]] | |||
: "In high-risk pregnant women, noninvasive prenatal testing with the use of massively parallel sequencing of maternal plasma cell-free DNA (cfDNA testing) accurately detects fetal autosomal aneuploidy. Its performance in low-risk women is unclear. ...In a general obstetrical population, prenatal testing with the use of cfDNA had significantly lower false positive rates and higher positive predictive values for detection of trisomies 21 and 18 than standard screening. (Funded by Illumina; ClinicalTrials.gov number, NCT01663350.)." | |||
(More? [[Trisomy 21]] | [[Trisomy 18]] | [[Prenatal Diagnosis]]) | |||
Reference: <pubmed>24571752</pubmed>| [http://www.nejm.org/doi/full/10.1056/NEJMoa1311037 N Engl J Med.] | |||
[[Template_talk:Main_Page_News|Older News Articles]] | |||
* RIKEN Panel Finds Misconduct in Reprogrammed Stem Cell Papers [http://www.riken.jp/en/pr/press/2014/20140401_2/RIKEN press release April 1, 2014] | [http://news.sciencemag.org/asiapacific/2014/04/riken-panel-finds-misconduct-reprogrammed-stem-cell-papers Science April 2014] | |||
===January=== | ===January=== |
Revision as of 12:27, 18 April 2014
The following are earlier versions of the news panel that appears on the website Main Page.
2014
March
- "In high-risk pregnant women, noninvasive prenatal testing with the use of massively parallel sequencing of maternal plasma cell-free DNA (cfDNA testing) accurately detects fetal autosomal aneuploidy. Its performance in low-risk women is unclear. ...In a general obstetrical population, prenatal testing with the use of cfDNA had significantly lower false positive rates and higher positive predictive values for detection of trisomies 21 and 18 than standard screening. (Funded by Illumina; ClinicalTrials.gov number, NCT01663350.)."
(More? Trisomy 21 | Trisomy 18 | Prenatal Diagnosis)
Reference: <pubmed>24571752</pubmed>| N Engl J Med.
- RIKEN Panel Finds Misconduct in Reprogrammed Stem Cell Papers press release April 1, 2014 | Science April 2014
January
News - Stimulus-triggered fate conversion of somatic cells into pluripotency | |
|
Is STAP Real?
- RIKEN Panel Finds Misconduct in Reprogrammed Stem Cell Papers Science April 2014
- Japanese research institute has opened an investigation into this groundbreaking stem cell study after concerns were raised about its credibility. The RIKEN investigation follows allegations on blog sites about the use of duplicated images in Obokata’s papers, and numerous failed attempts to replicate her results. Nature
2013
2012 Nobel Prize for Stem Cells | |
Stem Cell Signaling
The Nobel Prize in Physiology or Medicine 2012 was awarded jointly to Sir John B. Gurdon and Shinya Yamanaka "for the discovery that mature cells can be reprogrammed to become pluripotent"
(More? Yamanaka Factors | Induced Stem Cells | Stem Cells) |